Pharma tariffs widen September 29: 100% duty reaches every importer
US Section 232 tariffs on patented pharmaceuticals extend to all remaining importers on September 29, 2026 at a headline rate of 100%. Generics are excluded and country caps cut the rate to 10% to 15% for major origins, but retail pharmacy still faces the cost through acquisition prices and footfall.